We provided the first experimental evidence that spinal D1DR and D2DR might promote chronic bone cancer pain through forming D1/D2DR heteromers, thereby leading to the activation of Gq proteins and the downstream CaMKII and MAPK signaling to increase excitability in spinal neurons. Here, CAMK2G is linked to bone neoplasm.